a public good project by the
Synthesis
Company
of California

© 2026

Heinrike Schmeling | doi.page

0 works0 citations0 h-index

Heinrike Schmeling

University of Calgary(CA)Alberta Children's Hospital(CA)

Publications by Year

Research Areas

Autoimmune and Inflammatory Disorders Research, Adolescent and Pediatric Healthcare, Acute Lymphoblastic Leukemia research, Rheumatoid Arthritis Research and Therapies, Inflammatory Myopathies and Dermatomyositis

Most-Cited Works

→ Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry(2008)277 cited
→ The outcomes of juvenile idiopathic arthritis in children managed with contemporary treatments: results from the ReACCh-Out cohort(2014)258 cited
→ Distinct interferon signatures and cytokine patterns define additional systemic autoinflammatory diseases(2019)230 cited
→ Monitoring neutrophil activation in juvenile rheumatoid arthritis by S100A12 serum concentrations(2004)185 cited
→ Etanercept and uveitis in patients with juvenile idiopathic arthritis(2005)169 cited
→ Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: A history of statins and experience from a large international multi-center study(2016)131 cited

→ Consensus treatments for moderate juvenile dermatomyositis: Beyond the first two months. Results of the Second Childhood Arthritis and Rheumatology Research Alliance Consensus Conference(2011)

125 cited

→ The risk and nature of flares in juvenile idiopathic arthritis: results from the ReACCh-Out cohort(2015)115 cited

→ Clinical Characteristics of Children With Juvenile Dermatomyositis: The Childhood Arthritis and Rheumatology Research Alliance Registry(2013)109 cited

→ Nailfold capillary density is importantly associated over time with muscle and skin disease activity in juvenile dermatomyositis(2010)79 cited